What is the future of facilities dedicated to COVID?

According to the World Health Organization (WHO), prevention and treatment services for non-contagious diseases have been partially disrupted since the beginning of the COVID-19 pandemic.

WHO General Director, Dr. Tedros Adhanom Ghebreyesus was quoted as saying: “It is vital that countries find innovative ways to ensure that essential services for chronic diseases continue while at the same time fighting COVID-19”. 

Around the world, many specialist resources outside non-communicable diseases were partially or completely reassigned to support COVID-19 care, while scheduled treatments and public monitoring programs were postponed.  

Scientists expect the virus to become endemic, although it could potentially pose less of a threat over time as communities develop some immunity and symptoms become milder, and cases less severe. However, we will need to remain prepared for potential future outbreaks that could put pressure on the health system.  

We asked our members to share their thoughts about the possibility of introducing COVID-19 specific facilities, with an overwhelming majority agreeing that they will be needed moving forward.  

Would you like to receive the M3 Pulse directly to your inbox and take part in paid market research?

Join M3 Global Research

Share your opinion and get rewarded

Register as healthcare professional

Leave a Reply

Join Today

Registration is free and only takes a few clicks

Panel Members

Check your available studies

latest posts

emerging respiratory treatments for lung cancer - cystic fibrosis - robotic navigation - gene-editing nanoparticles

Emerging Respiratory Treatments: Frontiers in Pulmonology

Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.

Paid Studies About Medical Devices | M3 Guide

Real-World Evidence studies collect real-world data to evaluate the safety and performance of medical devices. This M3 Guide reveals how we conduct Real-World Evidence studies, how they contribute to better patient outcomes, and how healthcare professionals can get compensated.